Literature DB >> 12006452

Incidence and outcome of polymicrobial ventilator-associated pneumonia.

Alain Combes1, Corinne Figliolini, Jean-Louis Trouillet, Najibi Kassis, Michel Wolff, Claude Gibert, Jean Chastre.   

Abstract

STUDY
OBJECTIVE: To determine the epidemiology and outcome of polymicrobial ventilator-associated pneumonia (VAP).
SETTING: Two ICUs (18 and 17 beds) in a university hospital. DESIGN AND PATIENTS: We undertook a 16-month study of 124 patients in whom a first episode of VAP had been diagnosed. Patients in whom there was a suspicion of clinical or radiologic VAP underwent bronchoscopy, and VAP was confirmed by the presence of at least two of the following criteria: > or = 2% of cells with intracellular bacteria found on direct examination of BAL fluid (BALF); protected-specimen brush sample culture with > or = 10(3) cfu/mL; or BALF culture with > or = 10(4) cfu/mL.
RESULTS: Monomicrobial infections were diagnosed in 65 patients (52%), and polymicrobial infections were diagnosed in 59 patients (48%). Two different bacteria were isolated in 42 patients (34%), three different bacteria were isolated in 10 patients (8%), and four different bacteria were isolated in 7 patients (6%). Patients' clinical characteristics at ICU admission and on the day of bronchoscopy were similar, particularly the prior duration of mechanical ventilation (MV), the type of ICU admission, disease severity scores, and antibiotic therapy received before VAP was diagnosed. The percentages of nonfermenting, Gram-negative bacilli and methicillin-resistant staphylococci involved in monomicrobial and polymicrobial episodes were similar. Furthermore, no significant difference was detected in outcome parameters, specifically in the mortality rate at 30 days, the ICU mortality rate, the duration of MV, and the rate of infection relapse.
CONCLUSION: In our study population, the epidemiology and outcomes of patients with monomicrobial and polymicrobial VAP did not differ significantly.

Entities:  

Mesh:

Year:  2002        PMID: 12006452     DOI: 10.1378/chest.121.5.1618

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  29 in total

1.  Aliens, anaerobes, and the lung!

Authors:  Paul Marik
Journal:  Intensive Care Med       Date:  2003-07       Impact factor: 17.440

2.  Aetiological agents of ventilator-associated pneumonia and its resistance pattern - a threat for treatment.

Authors:  Mv Pravin Charles; Joshy M Easow; Noyal M Joseph; M Ravishankar; Shailesh Kumar; Umadevi Sivaraman
Journal:  Australas Med J       Date:  2013-09-30

3.  Risk factors for acquisition of ventilator-associated pneumonia in adult intensive care units.

Authors:  Fariba Lahoorpour; Ali Delpisheh; Abdorrahim Afkhamzadeh
Journal:  Pak J Med Sci       Date:  2013-09       Impact factor: 1.088

4.  Interaction of Staphylococcus aureus and Acinetobacter baumannii during In Vitro β-Lactam Exposure.

Authors:  Nicholas M Smith; Alexa Ang; Fanny Tan; Katelyn Macias; Sarah James; Jasleen Sidhu; Justin R Lenhard
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

5.  A coup d'état by NDM-producing Klebsiella pneumoniae overthrows the major bacterial population during KPC-directed therapy.

Authors:  Justin R Lenhard; Amisha P Rana; Eric Wenzler; Yanqin Huang; Barry N Kreiswirth; Liang Chen; Zackery P Bulman
Journal:  Diagn Microbiol Infect Dis       Date:  2020-05-15       Impact factor: 2.803

6.  Isolation of Mycoplasma hominis in critically ill patients with pulmonary infections: clinical and microbiological analysis in an intensive care unit.

Authors:  Celia García; Estibaliz Ugalde; Idoia Monteagudo; Ana Saez; Jesús Agüero; Luis Martinez-Martinez; Eduardo Miñambres
Journal:  Intensive Care Med       Date:  2006-11-08       Impact factor: 17.440

7.  Pseudomonas aeruginosa induces localized immunosuppression during pneumonia.

Authors:  Maureen H Diaz; Ciara M Shaver; John D King; Srinidhi Musunuri; Jeffrey A Kazzaz; Alan R Hauser
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

8.  Outcome of ventilator-associated pneumonia: Impact of antibiotic therapy and other factors.

Authors:  Noyal Mariya Joseph; Sujatha Sistla; Tarun Kumar Dutta; Ashok Shankar Badhe; Desdemona Rasitha; Subhash Chandra Parija
Journal:  Australas Med J       Date:  2012-02-29

9.  Variation of infected cell count in bronchoalveolar lavage and timing of ventilator-associated pneumonia.

Authors:  Hervé Dupont; Viviane Chalhoub; Gaëtan Plantefève; Cyrille De Vaumas; Nathalie Kermarrec; Catherine Paugam-Burtz; Jean Mantz
Journal:  Intensive Care Med       Date:  2004-05-13       Impact factor: 17.440

10.  Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p.

Authors:  Brian M Peters; Ekaterina S Ovchinnikova; Bastiaan P Krom; Lisa Marie Schlecht; Han Zhou; Lois L Hoyer; Henk J Busscher; Henny C van der Mei; Mary Ann Jabra-Rizk; Mark E Shirtliff
Journal:  Microbiology       Date:  2012-08-23       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.